Peptide Bivalirudin Trifluoroacetate CAS NO.128270-60-0

Quality

Our company is a professional production of hormone intermediates for many years, our products have exported to Germany,Spain, UK, USA, Australia, Middle East, and so on other country, and we have got very good feedback from our customers, you can trust us.And we are the manufactory, so no problem for us to control the quality.

Payment Method

Western Union,TT,Money Gram 

Service 

Best service with after-sales service to all clients.

Delivery

Sample Order :Package will be shipped with 3days after payment. We can send it via UP, EMS, HK Air Post, DHL or othermethod. We have a professional and stable logistics, and we can deliver the package smoothly around 3 to 5 days.

Peptide Bivalirudin Trifluoroacetate 

Molecular Formula：

C₉₈H₁₃₈N₂₄O₃₃

Relative Molecular Mass：

2180.32 g/mol

CAS-Number：

128270-60-0 (net)

Long-term Storage：

-20 ± 5 °C

Synonyms：

BG 8967; Hirulog; Hirulog I

Sequence：

H-D-Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly-Asn-Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-OH trifluoroacetate salt

Fields of Application：

Moderate to high risk acute coronary syndromes

Percutaneous coronary intervention

Active Substance：

Bivalirudin is a synthetic hirudin analog. Bivalirudin acts as a specific and reversible direct thrombin inhibitor.

------Product Description------

Bivalirudin is a new synthetic anticoagulant, thrombin direct, specific, reversible inhibitor. Initially developed by the Swiss company of Biogen (Biogen) successfully transferred to the United States after the MedicinesCompany, approved in 2000 in the United States. Its anticoagulant component is a hirudin-derived 20-peptide compound. Whether thrombin in the blood circulation, or thrombin-bound thrombin, bivalirudin can be combined with its catalytic site and anionic binding sites of specific binding, thereby inhibiting the activity of thrombin directly, and its role is characterized by a brief ,reversible. Early clinical studies have shown that anticoagulant therapy with bivalirudin is more effective and has a lower incidence of bleeding events and is safer than conventional heparin anticoagulation. Mainly for the prevention of angioplasty interventional treatment of unstable angina before and after ischemic complications.

-----Company Info------ 

Filter Biotechnology Co., Ltd is a High-Tech Bio-Chemical Enterprise which is integrated by Professional Scientific R&D, Mass production and Sales. As a world-leading Provider of Peptide Reagents, Generic Peptides and Custom Peptide Synthesis Services., it has been faithfully serving the Biotech and Pharmaceutical Industries, as well as well as life science research institutes, Universities and Medical Cosmetology Organization worldwide. 

In accordance with Relevant Regulations in China, , xxx certified with GMP Certification, actively implemented international Quality Standards and established a perfect Quality Management System. 

With the linking Enterprise Quality Assurance Agences and conscientious Quality Standard Audit Systems, it could gurantee the Good Quality on the Production Process and the Finished goods. 

Insisting on Faith, Mutual Beneficial Cooperation and Professional, conscientious and efficient work practices and combining the Excellent Inner Techniques and External Resources, XXX fully respect on Clients requirements to actively offer Highly Standard, Specialiezed and Professional Services around the world .

-----Lab-----

-----Contact US -----

Krystal 

Phone :0086-15737953140

Facebook :calarhan1993@126.com

Skype :calarhan1993@126.com